Edesa Biotech Inc reports results for the quarter ended in March - Earnings Summary

Edesa Biotech

13/05/2022 15:50

* Edesa Biotech Inc  EDSA.OQ  reported a quarterly adjusted
loss
of 33 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 37 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Edesa Biotech Inc's reported EPS for the quarter was a
loss
of 33 cents​.
    * The mean earnings estimate of analysts had risen by
about 10.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Edesa Biotech Inc shares had fallen by 38.4% this
quarter and
lost 67.5% so far this year.
    * The company reported a quarterly loss of $4.57 million.
    * Wall Street's median 12-month price target for Edesa
Biotech Inc
is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 13 at 02:50 p.m.  ​All
figures in US dollars unless otherwise stated